114 related articles for article (PubMed ID: 2138568)
1. Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement.
Beyaert R; Suffys P; Van Roy F; Fiers W
FEBS Lett; 1990 Mar; 262(1):93-6. PubMed ID: 2138568
[TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis.
Hullin F; Raynal P; Ragab-Thomas JM; Fauvel J; Chap H
J Biol Chem; 1989 Feb; 264(6):3506-13. PubMed ID: 2521636
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells.
Solito E; Raugei G; Melli M; Parente L
FEBS Lett; 1991 Oct; 291(2):238-44. PubMed ID: 1834480
[TBL] [Abstract][Full Text] [Related]
4. Partial mediation of glucocorticoid antiproliferative effects by lipocortins.
Almawi WY; Saouda MS; Stevens AC; Lipman ML; Barth CM; Strom TB
J Immunol; 1996 Dec; 157(12):5231-9. PubMed ID: 8955167
[TBL] [Abstract][Full Text] [Related]
5. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice.
Errasfa M; Russo-Marie F
Br J Pharmacol; 1989 Aug; 97(4):1051-8. PubMed ID: 2529014
[TBL] [Abstract][Full Text] [Related]
6. Lipocortin-I inhibits the synthesis and release of prolactin from human decidual cells: evidence for autocrine/paracrine regulation by lipocortin-I.
Pihoker C; Feeney RJ; Su JL; Handwerger S
Endocrinology; 1991 Feb; 128(2):1123-8. PubMed ID: 1824932
[TBL] [Abstract][Full Text] [Related]
7. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma.
Violette SM; King I; Browning JL; Pepinsky RB; Wallner BP; Sartorelli AC
J Cell Physiol; 1990 Jan; 142(1):70-7. PubMed ID: 2137129
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance.
Wu YL; Jiang XR; Lillington DM; Newland AC; Kelsey SM
Br J Haematol; 2000 Dec; 111(3):807-16. PubMed ID: 11122142
[TBL] [Abstract][Full Text] [Related]
9. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se.
Suffys P; Beyaert R; De Valck D; Vanhaesebroeck B; Van Roy F; Fiers W
Eur J Biochem; 1991 Jan; 195(2):465-75. PubMed ID: 1847684
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 inhibitory activity in thymocytes of dexamethasone-treated mice--possible implication of lipocortins.
Errasfa M; Rothhut B; Russo-Marie F
Biochem Biophys Res Commun; 1989 Feb; 159(1):53-60. PubMed ID: 2522304
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger.
Bienkowski MJ; Petro MA; Robinson LJ
J Biol Chem; 1989 Apr; 264(11):6536-44. PubMed ID: 2522933
[TBL] [Abstract][Full Text] [Related]
12. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism.
Suffys P; Beyaert R; Van Roy F; Fiers W
Biochem Biophys Res Commun; 1987 Dec; 149(2):735-43. PubMed ID: 3122740
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of a lipocortin in the initiation of DNA synthesis by human endothelial cells.
Patte C; Rothhut B; Russo-Marie F; Blanquet PR
Exp Cell Res; 1991 Nov; 197(1):12-20. PubMed ID: 1833215
[TBL] [Abstract][Full Text] [Related]
14. Modulation of tumor necrosis factor-alpha cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism.
Hepburn A; Boeynaems JM; Fiers W; Dumont JE
Biochem Biophys Res Commun; 1987 Dec; 149(2):815-22. PubMed ID: 3122742
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone inhibits the cytotoxic activity of tumor necrosis factor.
Tsujimoto M; Okamura N; Adachi H
Biochem Biophys Res Commun; 1988 May; 153(1):109-15. PubMed ID: 3377783
[TBL] [Abstract][Full Text] [Related]
16. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor.
Neale ML; Fiera RA; Matthews N
Immunology; 1988 May; 64(1):81-5. PubMed ID: 3133309
[TBL] [Abstract][Full Text] [Related]
17. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.
Ferreira SH; Cunha FQ; Lorenzetti BB; Michelin MA; Perretti M; Flower RJ; Poole S
Br J Pharmacol; 1997 Jul; 121(5):883-8. PubMed ID: 9222544
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action of glucocorticoids: role of lipocortins].
Tranchant C; Braun S; Warter JM
Rev Neurol (Paris); 1989; 145(12):813-8. PubMed ID: 2533385
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
Machuca C; Mendoza-Milla C; Córdova E; Mejía S; Covarrubias L; Ventura J; Zentella A
BMC Cell Biol; 2006 Feb; 7():9. PubMed ID: 16504042
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1.
Carollo M; Parente L; D'Alessandro N
Oncol Res; 1998; 10(5):245-54. PubMed ID: 9802059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
